{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:12:58Z","timestamp":1777381978575,"version":"3.51.4"},"reference-count":37,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2025,11,14]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to identify pretreatment factors associated with skeletal muscle mass (SMM) loss during first-line chemotherapy in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-centre retrospective study included 108 patients aged \u226570 years with diffuse large B-cell lymphoma (DLBCL) who completed first-line rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone or rituximab, cyclophosphamide, tetrahydropyranyl-adriamycin, vincristine, prednisone therapy. Skeletal muscle index (SMI, cm\u00b2\/m\u00b2) was calculated by dividing the cross-sectional muscle area at the third lumbar vertebra on abdominal CT by height squared. The percentage SMI loss was derived from pretreatment and post-treatment measurements. Patients were dichotomised into SMI-loss and SMI-maintained groups using the median SMI loss (5.9%) as the cut-off. Logistic regression was performed using SMI loss as the dependent variable and pretreatment factors as predictors. A sensitivity analysis using the Firth correction was also conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 108 patients, 54 (50%) were classified into each group. High pretreatment Glasgow Prognostic Score (GPS=2) independently predicted SMI loss (adjusted OR: 2.96; 95%\u2009CI 1.17 to 7.53; p=0.023). This association remained significant in the Firth-corrected model (OR: 1.59; 95%\u2009CI 1.01 to 2.58; p=0.041). Patients with high GPS more often exhibited B symptoms, elevated lactate dehydrogenase, poor International Prognostic Index scores, reduced performance status (PS) and low haemoglobin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pretreatment GPS may serve as a surrogate marker for SMM loss risk during first-line chemotherapy in elderly patients with DLBCL. Inflammation, malnutrition, reduced physical activity and poor PS may all contribute to SMM loss. Early exercise and nutritional interventions should be considered for patients with high GPS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2025-005797","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T11:40:12Z","timestamp":1765366812000},"page":"696-702","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of skeletal muscle loss during first-line therapy in diffuse large B-cell lymphoma: the Glasgow Prognostic Score"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4316-467X","authenticated-orcid":false,"given":"Takayuki","family":"Nakagami","sequence":"first","affiliation":[{"name":"Department of Rehabilitation, Hamamatsu Medical Center, Hamamatsu, Japan"},{"name":"Department of Rehabilitation Medicine, Keio University Graduate School, Shinjuku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9571-7332","authenticated-orcid":false,"given":"Aiko","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Physical Therapy, Faculty of Health Science, Juntendo University, Bunkyo, Japan"},{"name":"Department of Rehabilitation Medicine, Keio University School of Medicine, Shinjuku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Keio University School of Medicine, Shinjuku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hamamatsu Medical Center, Hamamatsu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"2026042802201394000_16.3.696.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237509","article-title":"Nationwide claims database analysis of treatment patterns, costs and survival of Japanese patients with diffuse large B-cell lymphoma","volume":"15","author":"Tsutsu\u00e9","year":"2020","journal-title":"PLoS One"},{"key":"2026042802201394000_16.3.696.2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.00102"},{"key":"2026042802201394000_16.3.696.3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu540"},{"key":"2026042802201394000_16.3.696.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2018.02.003"},{"key":"2026042802201394000_16.3.696.5","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16232"},{"key":"2026042802201394000_16.3.696.6","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1634\/theoncologist.2019-0406","article-title":"Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis","volume":"25","author":"Mohamed","year":"2020","journal-title":"Oncologist"},{"key":"2026042802201394000_16.3.696.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2499-4"},{"key":"2026042802201394000_16.3.696.8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jcsm.13126","article-title":"The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis","volume":"14","author":"Fang","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026042802201394000_16.3.696.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.04.115"},{"key":"2026042802201394000_16.3.696.10","doi-asserted-by":"crossref","first-page":"1247341","DOI":"10.3389\/fonc.2023.1247341","article-title":"Sarcopenia as a prognostic indicator in colorectal cancer: an updated meta-analysis","volume":"13","author":"He","year":"2023","journal-title":"Front Oncol"},{"key":"2026042802201394000_16.3.696.11","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14210"},{"key":"2026042802201394000_16.3.696.12","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16278"},{"key":"2026042802201394000_16.3.696.13","doi-asserted-by":"crossref","first-page":"101603","DOI":"10.1016\/j.clinre.2020.101603","article-title":"Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study","volume":"45","author":"Gallois","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2026042802201394000_16.3.696.14","first-page":"281","article-title":"Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer","volume":"95","author":"Motoori","year":"2018","journal-title":"Oncology (Williston Park, NY)"},{"key":"2026042802201394000_16.3.696.15","doi-asserted-by":"publisher","DOI":"10.1136\/spcare-2024-004870"},{"key":"2026042802201394000_16.3.696.16","first-page":"1860","article-title":"Report of the Committee on Hodgkin\u2019s Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"2026042802201394000_16.3.696.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"2026042802201394000_16.3.696.18","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/82.4.777"},{"key":"2026042802201394000_16.3.696.19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601242"},{"key":"2026042802201394000_16.3.696.20","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24015"},{"key":"2026042802201394000_16.3.696.21","doi-asserted-by":"publisher","DOI":"10.1139\/H08-075"},{"key":"2026042802201394000_16.3.696.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2013.11.007"},{"key":"2026042802201394000_16.3.696.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2012.08.003"},{"key":"2026042802201394000_16.3.696.24","article-title":"Characteristics of muscle function and the effect of cachexia in patients with haematological malignancy","volume":"28","author":"Fukushima","year":"2019","journal-title":"Eur J Cancer Care"},{"key":"2026042802201394000_16.3.696.25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jcsm.12524","article-title":"Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer","volume":"11","author":"Huang","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026042802201394000_16.3.696.26","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1245\/s10434-016-5188-1","article-title":"Skeletal Muscle Changes After Elective Colorectal Cancer Resection: A Longitudinal Study","volume":"23","author":"Malietzis","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2026042802201394000_16.3.696.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.06.011"},{"key":"2026042802201394000_16.3.696.28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10040104","article-title":"The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies","volume":"10","author":"Craver","year":"2018","journal-title":"Cancers (Basel)"},{"key":"2026042802201394000_16.3.696.29","first-page":"5499","article-title":"Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin\u2019s lymphoma cells and act as cooperative growth factors","volume":"56","author":"Voorzanger","year":"1996","journal-title":"Cancer Res"},{"key":"2026042802201394000_16.3.696.30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1200\/JCO.1995.13.3.575","article-title":"Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma","volume":"13","author":"Seymour","year":"1995","journal-title":"J Clin Oncol"},{"key":"2026042802201394000_16.3.696.31","first-page":"3562","article-title":"The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group","volume":"92","author":"Blay","year":"1998","journal-title":"Blood"},{"key":"2026042802201394000_16.3.696.32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev-immunol-101320-125839","article-title":"Immune Mechanisms in Inflammatory Anemia","volume":"41","author":"Canny","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"2026042802201394000_16.3.696.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2013.07.016"},{"key":"2026042802201394000_16.3.696.34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000360068","article-title":"Serum lactate dehydrogenase with a systemic inflammation score is useful for predicting response and survival in patients with newly diagnosed diffuse large B-cell lymphoma","volume":"133","author":"Jung","year":"2015","journal-title":"Acta Haematol"},{"key":"2026042802201394000_16.3.696.35","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2026042802201394000_16.3.696.36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/01635581.2024.2406043","article-title":"Effect of Combined Exercise and Nutrition Interventions During Inpatient Chemotherapy in Acute Leukemia and Malignant Lymphoma Patients: A Randomized Controlled Trial","volume":"77","author":"Kasahara","year":"2025","journal-title":"Nutr Cancer"},{"key":"2026042802201394000_16.3.696.37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2340\/1651-226X.2025.42056","article-title":"The effectiveness of exercise-based interventions on muscle mass, muscle strength, functional performance, aerobic capacity, and health-related quality of life in adults with malignant lymphoma undergoing chemotherapy: a systematic review of randomized controlled trials","volume":"64","author":"Groenset","year":"2025","journal-title":"Acta Oncol"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2025-005797","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:22:34Z","timestamp":1777368154000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2025-005797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4,28]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/spcare-2025-005797"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2025-005797","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]}}}